Generation and Characterization of Functional Cardiomyocytes Derived from Human T Cell-Derived Induced Pluripotent Stem Cells
暂无分享,去创建一个
M. Murata | Yusuke Kuroda | S. Yuasa | Toru Egashira | T. Seki | Masaki Kodaira | Tomoyuki Suzuki | H. Hashimoto | Shinichiro Okata | A. Tanaka | K. Fukuda | K. Yae | D. Kusumoto | S. Tohyama | Akira Kunitomi | Yuki Saito | Yoshikazu Kishino | M. Okada | M. Takei | J. Fujita | Atsushi Tanaka | Tomohisa Seki | Marina Okada
[1] Lior Gepstein,et al. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. , 2013, European heart journal.
[2] Philip Wong,et al. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. , 2013, European heart journal.
[3] Karl-Ludwig Laugwitz,et al. Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Versatile Tool for Arrhythmia Research , 2013, Circulation research.
[4] B. Knollmann,et al. Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Boutique Science or Valuable Arrhythmia Model? , 2013, Circulation research.
[5] S. Yuasa,et al. Novel insights into disease modeling using induced pluripotent stem cells. , 2013, Biological & pharmaceutical bulletin.
[6] Euan A Ashley,et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.
[7] Fred H. Gage,et al. Induced pluripotent stem cells: the new patient? , 2012, Nature Reviews Molecular Cell Biology.
[8] Takashi Daimon,et al. Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.
[9] Shinsuke Yuasa,et al. Disease characterization using LQTS-specific induced pluripotent stem cells. , 2012, Cardiovascular research.
[10] Takashi Aoi,et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.
[11] Euan A. Ashley,et al. Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.
[12] Ofer Binah,et al. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation , 2012, Journal of cellular and molecular medicine.
[13] S. Baek,et al. Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[14] James W. Smyth,et al. The gap junction life cycle. , 2012, Heart rhythm.
[15] D. Malan,et al. Cardiomyocytes Obtained From Induced Pluripotent Stem Cells With Long-QT Syndrome 3 Recapitulate Typical Disease-Specific Features In Vitro , 2011, Circulation research.
[16] Stéphanie Boué,et al. Methods for making induced pluripotent stem cells: reprogramming à la carte , 2011, Nature Reviews Genetics.
[17] Jonathan A. Bernstein,et al. Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome , 2011, Nature.
[18] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[19] J. Itskovitz‐Eldor,et al. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells , 2009, Journal of cellular and molecular medicine.
[20] I. Ishida,et al. Direct generation of induced pluripotent stem cells from human nonmobilized blood. , 2011, Stem cells and development.
[21] Karl-Ludwig Laugwitz,et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.
[22] Shinsuke Yuasa,et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. , 2010, Cell stem cell.
[23] R. Jaenisch,et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. , 2010, Cell stem cell.
[24] S. Yamanaka. Patient-specific pluripotent stem cells become even more accessible. , 2010, Cell stem cell.
[25] G. Church,et al. Reprogramming of T cells from human peripheral blood. , 2010, Cell stem cell.
[26] E. Nuwaysir,et al. Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes , 2010, PloS one.
[27] Lei Yang,et al. Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome , 2010, Nature.
[28] Lior Gepstein,et al. Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells , 2009, Circulation.
[29] Shinsuke Yuasa,et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. , 2009, Biochemical and biophysical research communications.
[30] Yunyu Zhang,et al. Wnt3a‐Induced Mesoderm Formation and Cardiomyogenesis in Human Embryonic Stem Cells , 2009, Stem cells.
[31] Sean P. Palecek,et al. Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.
[32] S. Yuasa,et al. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era , 2008, Expert review of cardiovascular therapy.
[33] Katsushi Tokunaga,et al. HLA-haplotype banking and iPS cells , 2008, Nature Biotechnology.
[34] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[35] M. Zaugg,et al. Integration of calcium with the signaling network in cardiac myocytes. , 2006, Journal of molecular and cellular cardiology.
[36] Norio Nakatsuji,et al. Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. , 2006, Biochemical and biophysical research communications.
[37] P. Doevendans,et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells * , 2002, Journal of anatomy.
[38] R. Jaenisch,et al. Monoclonal mice generated by nuclear transfer from mature B and T donor cells , 2002, Nature.
[39] L Gepstein,et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.
[40] D. Conner. Mouse embryo fibroblast (MEF) feeder cell preparation. , 2001, Current protocols in molecular biology.